Pediatric emergency medicine trisk 1180

fine-needle aspiration, 114
history and physical examination, 114 , 114 t
mammography, 114
fibroadenoma, 111
fibrocystic disease, 111 –112
gynecomastia, 113 –114
juvenile breast hypertrophy, 113
life-threatening, 111 t
physiologic mastalgia, 114
premature thelarche, 113
ultrasonography, 112
Breast milk jaundice, 295 , 298
Breath-holding spells, 518 , 882
Breathing
abnormalities, 1224
assessment of, 29
CPR management, 49 –50 , 50 f
evaluation, 49
Brief psychotic episode, 1440 –1442
Brief resolved unexplained events (BRUE), 102 , 103 t, 143
Bronchial atresia, 1407
Bronchial foreign body, 1119 f
Bronchiectasis, 574
Bronchiolitis, 133 –136 , 134 t, 480 , 569
Bronchogenic cysts, 1405 , 1415 , 1417 f
Bronchopulmonary dysplasia, 944 –945 , 945 f
Bronchopulmonary sequestrations (BPSs), 1415
Bronchoscopy, 1406 , 1409
Brown-Séquard syndrome, 1250 , 1250 f
Brucella, 848 , 1349
Brucellosis, 313

Brudzinski sign, 123
Brugada syndrome, 519 , 522
Bruise, 624 –625
Bruising, 623 –624
Bubonic plague, 253
Buccal mucosa laceration, 1167


Bulbar urethritis, 384 t
Bulimia nervosa, 570
Bullous impetigo, 439 , 439 f
Bullous pemphigoid, 448
Burkholderia cepacia , 946
Burkitt lymphoma, 909
Burns, 624 –625 , 1095 –1103
chemical, 1102 –1103
clinical assessment, 1096 –1097
clinical recognition, 1096
electrical, 1102
emergency care, goals of, 1095
fluid resuscitation formulas, 1100 t
inflicted, 1102
initial assessment, 1095 –1098
evidences, 1095 –1096
treatment goals, 1096
major
clinical assessment, 1098 –1099
clinical recognition, 1098
evidences, 1098
treatment goals, 1098

triage considerations, 1096 t, 1098
management, 1097 –1099
antibiotics, 1100
blisters, 1101
breathing, 1099
circulation, 1099
disposition, 1101
dressing, 1101 –1102
escharotomy, 1100
fluid resuscitation, 1099 –1100
pain, 1100 –1101
tetanus, 1100
wound care, 1100
meticulous antiseptic techniques, 1100
minor, 1101 –1102


partial-thickness, 1096 –1097
resuscitation, 1095 –1098
skin, classification, 1097 f
superficial, 1096 , 1097 f
surface area, estimation, 1097 f
triage considerations, 1096 , 1096 t
various depths, 1098 f
Bursitis, 405
Button battery, 206 , 208

C
Café-au-lait spots, 466
Calcifications, 1307

Calcium channel blockers (CCBs), 1044
Calcium chloride, 55 t
Calcium gluconate, 55 t
Campylobacter jejuni infection, 218 , 558 , 893
Canale–Smith syndrome, 312
Cancers of breast, 112
Candida albicans , 347 , 458 , 462 –463 , 510 , 534 , 1342
Candida infection, 443 –444 , 443 f
Candidal diaper dermatitis, 458 , 463
Candidal vulvovaginitis, 530 , 543
Candida psiloparis , 458
Candida vaginitis, 545
Candidiasis, 347
Cannabis poisoning, 1073 –1074
Cannabis sativa , 337
Capnography, 40
Carbamate insecticides, 1065
Carbamazepine, 456
Carbon monoxide poisoning, 503 , 685 –687
Carbohydrate disorders, 878
intolerance, 878
production, 878
Carbon monoxide poisoning
clinical recognition, 686


indications for discharge/admission, 687
management and diagnostic studies, 686 –687 , 687 t
treatment, goals of, 685
triage considerations, 686

Carboxyhemoglobinemia, 123
Carcinomas, 910
Cardiac arrest
pathways, 45 f
signs and symptoms of lack of oxygen/glucose, 47 f
Cardiac Arrest Registry to Enhance Survival (CARES), 44 , 57
Cardiac emergencies
acquired heart disease, 611 –612
acute heart failure syndromes (AHFS), 610 –611 , 611 t, 612 f
acute rheumatic fever, 614
arrhythmic emergencies, 600 –609
bacterial endocarditis, 614
cardiac tamponade, 614
cardiac trauma, 615 –616
cardiomyopathies, 612 –613
congenital heart disease (CHD), 588 –600
Kawasaki disease (KD), 615
myocardial ischemia (MI), 615
myocarditis, 613
patient evaluation with cardiac device, 616 –618
pericarditis, 613 –614
sudden cardiac death, 609 –610 , 611 f
therapy goals of, 588
Cardiac infections
brucella, 848
Chagas disease, 846
coronaviruses, 846
diphtheria, 847
lymphadenopathy, 847
measles, 847

mumps, 847 –848
Cardiac infectious emergencies
acquired heart disease, 611